This website uses third-party profiling cookies to provide services in line with the preferences you reveal while browsing the Website. By continuing to browse this Website, you consent to the use of these cookies. If you want to object such processing, please read the instructions described in our Cookie Policy.
I ACCEPT

Andrew Hopkins

Exscientia

Professor Andrew Hopkins, 47, spent a decade with Pfizer before launching Exscientia as a spinout from Dundee University in 2012. The company’s artificial intelligence technology is used to develop drugs. It has signed multimillion-pound research deals with Glaxo Smith Kline and Sanofi.

Request a Test Drive, a Quote or More Information